INSIGHTS ON CLINICAL TRIAL DESIGN
-
Integrating Clinical Operations And Pharmacovigilance for Safer Trials
Learn how integrated planning strengthens decision-making, reduces downstream risk, and supports patient safety while protecting timelines in high-risk studies.
-
A Mission To Expand Recruitment Territory
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
-
Patient Support Solutions For Clinical Trials
Learn how Greenphire leverages its more than 17 years of experience to deliver the most flexible and comprehensive patient-focused solutions and services.
-
Enhance Access And Improve Retention In Rare Disease Trials With HTS
Home Trial Support (HTS) provides a solution to improving participant recruitment and retention during musculoskeletal studies.
-
Overcoming Barriers To Clinical Trial Participation In Oncology12/3/2024
Oncology clinical trials face unique challenges in patient recruitment and retention due to barriers such as awareness, logistical constraints, and eligibility criteria.
-
Why Early Phase Speed Depends On Oncology Expertise5/1/2026
Early phase oncology speed depends on confident, oncology‑specific decisions made upfront. Learn why scientific expertise, realistic planning, and foresight determine whether programs maintain momentum.
-
Expectations For Plain Language Summaries Continue To Evolve11/7/2025
Plain language summaries (PLS) are growing in importance as a requirement in global transparency. Focusing on protocol and results summaries, we cover expectations and best practices for global PLS implementation.
-
The Impact Of High Inflation And The Great Resignation On Clinical Site Budgeting10/30/2024
The twin pressures of inflation and attrition prolong negotiations between sponsors and clinical sites, stalling drug development. Sponsors need up-to-date, reliable benchmark data to negotiate fair market value budgets.
-
Start-Up Speed vs. Total Trial Success: Balancing RTSM Priorities3/9/2026
Don't let a fast startup compromise years of clinical success. Learn how to balance initial build speed with the long-term flexibility needed to handle protocol amendments and complex integrations.
CLINICAL TRIAL DESIGN SOLUTIONS
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.
-
At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.
-
Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.